Jacobs John C bought NVAX
March 2, 2026 · Form 4 insider transaction
Jacobs John C bought 551,500 shares of Novavax, Inc. at $9.09 per share, a transaction worth $5.01M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
551,500
Price
$9.09
Total value
$5.01M
InsiderJacobs John C
RoleOfficer, Director
CompanyNovavax, Inc. (NVAX)
SecurityNon-Statutory Stock Option NQ
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after551,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.